We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Releases Guidance on Trials for Active Ingredients for Use in OTC Monographs
FDA Releases Guidance on Trials for Active Ingredients for Use in OTC Monographs
The FDA issued draft recommendations for designing and running a maximal usage trial (MUsT) for topical active ingredients that are being considered in an over-the-counter monograph.